New Biotechnology Allows for Epigenetics Edits
Finding new ways to treat inherited diseases has been a key priority for the biomedical sector. Now, Chroma Medicine, which is a new start-up with an impressive $125 million in funding plans to use gene editing in order to develop treatments that are designed to alter the epigenome.
View full press release